The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 14, 2023

Filed:

Apr. 01, 2021
Applicants:

The Regents of the University of California, Oakland, CA (US);

University of Vienna, Vienna, AT;

Emmanuelle Charpentier, Berlin, DE;

Inventors:

Jennifer A. Doudna, Berkeley, CA (US);

Martin Jinek, Berkeley, CA (US);

Krzysztof Chylinski, Vienna, AT;

Emmanuelle Charpentier, Berlin, DE;

Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12N 15/63 (2006.01); C12N 9/22 (2006.01); C12N 15/113 (2010.01); C12N 15/10 (2006.01); C12N 15/90 (2006.01); C12Q 1/686 (2018.01); H01L 33/00 (2010.01); H01L 21/02 (2006.01); C12N 15/70 (2006.01); C12N 15/74 (2006.01); A61K 38/46 (2006.01); A01H 6/46 (2018.01); A01K 67/027 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/907 (2013.01); A01H 6/4684 (2018.05); A01K 67/027 (2013.01); A61K 38/465 (2013.01); C12N 9/22 (2013.01); C12N 15/102 (2013.01); C12N 15/111 (2013.01); C12N 15/113 (2013.01); C12N 15/63 (2013.01); C12N 15/70 (2013.01); C12N 15/746 (2013.01); C12N 15/90 (2013.01); C12N 15/902 (2013.01); C12Q 1/686 (2013.01); H01L 21/02312 (2013.01); H01L 21/02365 (2013.01); H01L 33/0075 (2013.01); A61K 48/00 (2013.01); C12N 2310/11 (2013.01); C12N 2310/13 (2013.01); C12N 2310/14 (2013.01); C12N 2310/20 (2017.05); C12N 2310/31 (2013.01); C12N 2310/32 (2013.01); C12N 2310/33 (2013.01); C12N 2310/3519 (2013.01); C12N 2310/531 (2013.01); C12N 2800/80 (2013.01); C12Y 301/04 (2013.01);
Abstract

The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and/or a polypeptide associated with the target DNA The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multicellular organisms.


Find Patent Forward Citations

Loading…